+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Estrogen Receptor"

Estrogen Receptor - Pipeline Review, H2 2019 - Product Thumbnail Image

Estrogen Receptor - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 91 Pages
From
Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, and Others), By Regions (North America, Europe, Asia Pacific, and Rest of the World) - Global Forecast up to 2025 - Product Thumbnail Image

Osteoporosis Drugs Market - By Drug Class (Bisphosphonates, Parathyroid Hormone Therapy, Selective Estrogen Receptor Modulator, RANK Ligand Inhibitors, Biosimilars, and Others), By Regions (North America, Europe, Asia Pacific, and Rest of the World) - Global Forecast up to 2025

  • Report
  • September 2019
  • 70 Pages
From
Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018 - Product Thumbnail Image

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018

  • Drug Pipelines
  • September 2018
  • 83 Pages
From
Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H1 2018 - Product Thumbnail Image

Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H1 2018

  • Drug Pipelines
  • March 2018
  • 81 Pages
From
Steroid Hormone Receptor ERR1 (Estrogen Receptor Like 1 or Estrogen Related Receptor Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or NR3B1 or ESRRA) - Pipeline Review, H2 2017 - Product Thumbnail Image

Steroid Hormone Receptor ERR1 (Estrogen Receptor Like 1 or Estrogen Related Receptor Alpha or Nuclear Receptor Subfamily 3 Group B Member 1 or NR3B1 or ESRRA) - Pipeline Review, H2 2017

  • Drug Pipelines
  • August 2017
  • 25 Pages
From
Osteoporosis Drugs Market and Selective Estrogen Receptor Modulators for Male and Female Population: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021 - Product Thumbnail Image

Osteoporosis Drugs Market and Selective Estrogen Receptor Modulators for Male and Female Population: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 - 2021

  • Report
  • November 2016
  • 110 Pages
From
Osteoporosis Market Insights, Epidemiology and Market Forecast-2028 - Product Thumbnail Image

Osteoporosis Market Insights, Epidemiology and Market Forecast-2028

  • Drug Pipelines
  • December 2019
  • 180 Pages
From
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Ongoing Transition from Anti-Resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness. - Product Thumbnail Image

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Ongoing Transition from Anti-Resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness.

  • Report
  • July 2018
  • 138 Pages
From
Global Osteoporosis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2022 - Product Thumbnail Image

Global Osteoporosis Drugs Market Size, Share, Development, Growth and Demand Forecast to 2022

  • Report
  • November 2016
  • 94 Pages
From
  • 9 Results (Page 1 of 1)
Loading Indicator
adroll